Blade Air Mobility, Inc.: Business Overview, Financials & Competitive Analysis
Blade Air Mobility operates as a medical air transport company providing helicopter and air ambulance services for organ transplant logistics and medical teams across the United States. The company's passenger busines...
Cyborg Score thesis
Blade is repositioning as a specialized medical air transport operator with clearer market focus but significantly reduced scale...
Read the full analyst-debate transcript →Get the Latest Blade Air Mobility, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBlade Air Mobility, Inc. Overview
Pro stress-test →Blade Air Mobility operates as a medical air transport company providing helicopter and air ambulance services for organ transplant logistics and medical teams across the United States. The company's passenger business was acquired by Joby Aviation in August 2025, leaving the medical segment as its primary public operation.
Strategic Profile
Pro stress-test →Blade maintains a critical infrastructure role in emergency medical transport, competing in a niche but essential market for organ procurement and donor logistics coordination. The company is transitioning to focus exclusively on high-margin medical air services after spinning off its consumer-facing urban air mobility operations.
Competitive Landscape
Pro stress-test →Blade competes in the specialized medical air transport and organ procurement logistics market against regional air ambulance operators and helicopter charter services focused on emergency/medical transport. Primary competitors include Mercy Air and regional hospital-affiliated flight programs, though Blade's dedicated organ procurement focus provides differentiation.
Industry Context
Blade Air Mobility, Inc. operates in Public Safety and Emergency Services.
Key facts
Founded: 2014 · Headquarters: New York City, US · Employees: 246 (as of 2022; updated count post-divestiture not disclosed) · Revenue: Medical segment revenue data not separately disclosed post-divestiture; 2022 total company revenue was $146.1 million